Related Experiment Video
Updated: Aug 24, 2026

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Relations of Budd-Chiari syndrome to prothrombin gene mutation
Guo-Ling Lin1, Pei-Qin Xu, Hua Qi
1Department of General Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Insights
This study found no prothrombin gene mutation (FII G20210A) in Chinese Budd-Chiari syndrome (BCS) patients. Further research is needed to understand the causes of BCS in this population.
Area of Science:
- Hepatology
- Genetics
- Vascular Medicine
Background:
- Budd-Chiari syndrome (BCS) involves hepatic vein or inferior vena cava obstruction, leading to portal hypertension.
- The etiology of BCS is complex, with potential genetic links.
- Investigating gene mutations is crucial for understanding BCS pathogenesis.
Purpose of the Study:
- To determine if the prothrombin gene mutation (FII G20210A) is associated with Budd-Chiari syndrome in Chinese patients.
- To explore the correlativity between FII G20210A mutation and BCS occurrence.
Main Methods:
- Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was employed.
- Genome DNA was purified from whole blood samples of 38 BCS patients and 70 controls.
- DNA fragments were amplified, digested, and analyzed using polyacrylamide gel electrophoresis.
Main Results:
- The FII G20210A mutation was not detected in any of the studied BCS patients or control subjects.
- No evidence of a link between FII G20210A mutation and BCS was found.
Conclusions:
- The FII G20210A mutation is not present in Chinese patients diagnosed with BCS.
- There is no correlativity between the occurrence of BCS and the FII G20210A mutation in the Chinese population.
- The underlying causes of BCS in Chinese individuals require further investigation.
Background:
Budd-Chiari syndrome (BCS) is a type of disease characterized by portal hypertension and/or hypertension of the inferior vena cava (IVC) due to the obstruction of the hepatic veins (HV) and/or intrahepatic IVC outlet. Being etiologically complicated and obscure, BCS can be acquired or idiopathic and several gene mutations may be contributable. This study was to explore whether prothrombin gene mutation (FII G20210A) takes part in the pathogenesis of BCS and to investigate their correlativity.
Methods:
In 38 proven BCS patients and 70 controls, polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to find FII G20210A mutation. To detect whether there are any mutations, four steps were taken: purification of genome DNA from whole blood, amplification of special fragment by polymerase chain reaction, digestion of the fragment via restriction endonuclease, and analysis of results by polyacrylamide gel electrophoresis.
Results:
FII G20210A mutation was not detected in all patients and controls.
Conclusions:
No FII G20210A mutation exists in Chinese patients with BCS, nor correlativity between the occurrence of BCS and FII G20210A mutation. The etiology of BCS in the Chinese needs further investigation.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pedigree Analysis
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Genetic Lingo
Sex-linked Disorders
Single Nucleotide Polymorphisms-SNPs